+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genotyping Market by Technology (Microarray, Pcr, Sequencing), Application (Agriculture, Clinical Diagnostics, Research), End User, Sample Type - Global Forecast 2025-2030- Product Image
Genotyping Market by Technology (Microarray, Pcr, Sequencing), Application (Agriculture, Clinical Diagnostics, Research), End User, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Genotyping Market by Technology (Microarray, Pcr, Sequencing), Application (Agriculture, Clinical Diagnostics, Research), End User, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454849
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genotyping market is evolving rapidly, driven by escalating demand for advanced genetic analysis across research, diagnostics, and agriculture. Senior decision-makers must understand the latest industry shifts, technological progress, and structural changes to guide strategic investments and maximize opportunities in this vital sector.

Market Snapshot: Genotyping Market Growth and Outlook

The genotyping market grew from USD 23.63 billion in 2024 to USD 27.00 billion in 2025 and is projected to expand at a CAGR of 14.18%, reaching USD 52.37 billion by 2030. This robust growth reflects heightened adoption of high-throughput sequencing, digital PCR, and comprehensive analytic platforms in both established and emerging economies. Expanding deployment across clinical diagnostics, agriculture, and fundamental research is reinforcing the sector’s momentum while enhancing global innovation capacity.

Scope & Segmentation

  • Technology Platforms: Microarrays (including comparative genomic hybridization and SNP arrays), PCR (digital and real-time), sequencing (next-generation exome, targeted, whole genome, and Sanger).
  • Applications: Agriculture (crop improvement, livestock breeding), clinical diagnostics (cancer profiling, pathogen detection), research (gene expression analysis, genetic variation studies).
  • End User Categories: Academic and research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies.
  • Sample Types: Human, animal, microbial, and plant samples.
  • Regional Coverage: Americas (notably the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as Germany, France, the UK, UAE, South Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea).
  • Leading Companies: Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, PerkinElmer Inc., BGI Genomics Co. Ltd., Eurofins Scientific SE.

Key Takeaways: Strategic Insights for Genotyping Market Leadership

  • The convergence of sequencing, PCR, and microarray technologies is enhancing precision, data throughput, and versatility across applications.
  • Genotyping accelerates personalized medicine by enabling targeted therapeutic strategies, and plays a pivotal role in agricultural trait selection and food security initiatives.
  • Emerging interdisciplinary collaborations and systems biology approaches are expanding market reach, fostering integrated solutions across sectors.
  • Flexible workflow integration and sample processing enable organizations to address diverse sample types and evolving research questions effectively.
  • Regional differences in infrastructure, regulation, and funding call for tailored go-to-market strategies to achieve maximum market penetration and compliance.
  • Partnerships between technology providers and application specialists are accelerating innovation pipelines in both clinical and agricultural domains.

Tariff Impact: 2025 U.S. Tariffs and Genotyping Supply Chains

The 2025 United States tariff measures introduced cost pressures for instruments and consumables, leading manufacturers to diversify vendors and strengthen domestic production. These shifts influenced procurement strategies and prompted increased investment in local manufacturing for sequencing reagents and PCR kits. Organizations responded with process innovation, adopting targeted workflows and digital PCR to manage expenditure without compromising analytic output. Tariffs have also supported regional innovation, with new product lines and collaborations emerging within the Americas. Adaptability in technology adoption and proactive supply management now distinguish successful market participants.

Methodology & Data Sources

This report utilizes primary interviews with senior leaders and procurement experts, augmented by secondary research from peer-reviewed publications, patents, and policy analysis. Rigorous validation through cross-referencing and triangulation underpins all conclusions, ensuring actionable insights for decision-makers.

Why This Report Matters

  • Provides a comprehensive overview of genotyping technologies, applications, and market drivers, supporting informed investment and partnership decisions.
  • Delivers actionable segmentation and regional dynamics, enabling targeted strategy development and risk mitigation in fast-evolving markets.
  • Equips leaders to anticipate regulatory, supply chain, and technology trends, sustaining innovation and competitive resilience in the genotyping landscape.

Conclusion

The genotyping market will continue to advance through technological innovation, cross-sector collaboration, and regionally adaptive strategies. Informed decisions and agile planning will be essential for organizations aiming to lead and thrive in this dynamic field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of direct-to-consumer genotyping services with mobile app-enabled result interpretation
5.2. Adoption of high-throughput microarray platforms for polygenic risk score calculations in clinical settings
5.3. Integration of nanopore sequencing technologies for rapid on-site pathogen genotyping in agriculture
5.4. Implementation of artificial intelligence algorithms for automated variant calling and data annotation
5.5. Growth of pharmacogenomic-guided prescribing solutions to personalize medication regimens based on genotype
5.6. Collaboration between genomic data repositories and healthcare providers to enhance population-level genotype analysis
5.7. Emergence of point-of-care genotyping devices for real-time companion diagnostics in oncology treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genotyping Market, by Technology
8.1. Introduction
8.2. Microarray
8.2.1. Comparative Genomic Hybridization
8.2.2. Snp Array
8.3. Pcr
8.3.1. Digital
8.3.2. Real Time
8.4. Sequencing
8.4.1. Next Generation
8.4.1.1. Exome
8.4.1.2. Targeted
8.4.1.3. Whole Genome
8.4.2. Sanger
9. Genotyping Market, by Application
9.1. Introduction
9.2. Agriculture
9.2.1. Crop Improvement
9.2.2. Livestock Breeding
9.3. Clinical Diagnostics
9.3.1. Cancer Profiling
9.3.2. Pathogen Detection
9.4. Research
9.4.1. Gene Expression Analysis
9.4.2. Genetic Variation Studies
10. Genotyping Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Diagnostic Laboratories
10.4. Pharmaceutical And Biotechnology Companies
11. Genotyping Market, by Sample Type
11.1. Introduction
11.2. Animal
11.3. Human
11.4. Microbial
11.5. Plant
12. Americas Genotyping Market
12.1. Introduction
12.2. Canada
12.3. Argentina
12.4. Brazil
12.5. United States
12.6. Mexico
13. Europe, Middle East & Africa Genotyping Market
13.1. Introduction
13.2. Denmark
13.3. Poland
13.4. Germany
13.5. France
13.6. United Arab Emirates
13.7. Sweden
13.8. South Africa
13.9. Switzerland
13.10. United Kingdom
13.11. Israel
13.12. Netherlands
13.13. Turkey
13.14. Saudi Arabia
13.15. Finland
13.16. Spain
13.17. Qatar
13.18. Nigeria
13.19. Russia
13.20. Egypt
13.21. Italy
13.22. Norway
14. Asia-Pacific Genotyping Market
14.1. Introduction
14.2. Indonesia
14.3. Philippines
14.4. Malaysia
14.5. India
14.6. Thailand
14.7. South Korea
14.8. Taiwan
14.9. Japan
14.10. Australia
14.11. Vietnam
14.12. Singapore
14.13. China
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. QIAGEN N.V.
15.3.4. F. Hoffmann-La Roche Ltd
15.3.5. Agilent Technologies, Inc.
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. Danaher Corporation
15.3.8. PerkinElmer, Inc.
15.3.9. BGI Genomics Co., Ltd.
15.3.10. Eurofins Scientific SE
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GENOTYPING MARKET: RESEARCHAI
FIGURE 24. GENOTYPING MARKET: RESEARCHSTATISTICS
FIGURE 25. GENOTYPING MARKET: RESEARCHCONTACTS
FIGURE 26. GENOTYPING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENOTYPING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENOTYPING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENOTYPING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENOTYPING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENOTYPING MARKET SIZE, BY SNP ARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENOTYPING MARKET SIZE, BY SNP ARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENOTYPING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENOTYPING MARKET SIZE, BY DIGITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENOTYPING MARKET SIZE, BY REAL TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENOTYPING MARKET SIZE, BY REAL TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENOTYPING MARKET SIZE, BY EXOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENOTYPING MARKET SIZE, BY EXOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENOTYPING MARKET SIZE, BY TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENOTYPING MARKET SIZE, BY TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENOTYPING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENOTYPING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENOTYPING MARKET SIZE, BY SANGER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENOTYPING MARKET SIZE, BY SANGER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENOTYPING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENOTYPING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENOTYPING MARKET SIZE, BY LIVESTOCK BREEDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENOTYPING MARKET SIZE, BY LIVESTOCK BREEDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENOTYPING MARKET SIZE, BY CANCER PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENOTYPING MARKET SIZE, BY CANCER PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENOTYPING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENOTYPING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENOTYPING MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENOTYPING MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENOTYPING MARKET SIZE, BY GENETIC VARIATION STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENOTYPING MARKET SIZE, BY GENETIC VARIATION STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENOTYPING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENOTYPING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENOTYPING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENOTYPING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENOTYPING MARKET SIZE, BY ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENOTYPING MARKET SIZE, BY ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENOTYPING MARKET SIZE, BY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENOTYPING MARKET SIZE, BY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENOTYPING MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENOTYPING MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENOTYPING MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENOTYPING MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. CANADA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 114. CANADA GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 115. CANADA GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 116. CANADA GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 117. CANADA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 118. CANADA GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 119. CANADA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 124. CANADA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 125. CANADA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 126. CANADA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 127. CANADA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 128. CANADA GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 129. CANADA GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 206. MEXICO GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 207. MEXICO GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 208. MEXICO GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 209. MEXICO GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. MEXICO GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 218. MEXICO GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 219. MEXICO GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. MEXICO GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. DENMARK GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 250. DENMARK GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 251. DENMARK GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 252. DENMARK GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 253. DENMARK GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. DENMARK GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. DENMARK GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 262. DENMARK GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 263. DENMARK GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. DENMARK GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 265. DENMARK GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 268. DENMARK GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 269. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. POLAND GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 272. POLAND GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 273. POLAND GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 274. POLAND GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 275. POLAND GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 276. POLAND GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 277. POLAND GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 278. POLAND GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 279. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. POLAND GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 282. POLAND GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 283. POLAND GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 284. POLAND GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 285. POLAND GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 286. POLAND GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 287. POLAND GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. POLAND GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. POLAND GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 290. POLAND GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 291. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 294. GERMANY GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 295. GERMANY GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 296. GERMANY GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 297. GERMANY GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 298. GERMANY GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 299. GERMANY GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 300. GERMANY GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. GERMANY GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 304. GERMANY GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 305. GERMANY GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 308. GERMANY GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 309. GERMANY GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. GERMANY GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. GERMANY GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 313. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 314. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 315. FRANCE GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 316. FRANCE GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 317. FRANCE GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 318. FRANCE GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 319. FRANCE GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 320. FRANCE GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 321. FRANCE GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 322. FRANCE GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 323. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. FRANCE GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 326. FRANCE GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 327. FRANCE GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 328. FRANCE GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 329. FRANCE GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 330. FRANCE GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 331. FRANCE GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. FRANCE GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. FRANCE GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 334. FRANCE GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 357. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 358. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 359. SWEDEN GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 360. SWEDEN GENOTYPING MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 361. SWEDEN GENOTYPING MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 362. SWEDEN GENOTYPING MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 363. SWEDEN GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 364. SWEDEN GENOTYPING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 365. SWEDEN GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2024 (USD MILLION)
TABLE 366. SWEDEN GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2025-2030 (USD MILLION)
TABLE 367. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 368. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 369. SWEDEN GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 370. SWEDEN GENOTYPING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 371. SWEDEN GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 372. SWEDEN GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 373. SWEDEN GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 374. SWEDEN GENOTYPING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 375. SWEDEN GENOTYPING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 376. SWEDEN GENOTYPING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 377. SWEDEN GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 378. SWEDEN GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 379. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 380. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Genotyping market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 27 Billion
Forecasted Market Value ( USD ) by 2030 $ 52.37 Billion
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genotyping Assay Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Workflow - Global Forecast 2025-2030 - Product Image

Genotyping Assay Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Workflow - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Human MTHFR Genotyping Detection Kits Market by Technology (Microarray-Based, Pcr-Based, Sequencing-Based), Application (Clinical, Research), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Human MTHFR Genotyping Detection Kits Market by Technology (Microarray-Based, Pcr-Based, Sequencing-Based), Application (Clinical, Research), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Genotyping - Global Strategic Business Report - Product Image

Genotyping - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User - Product Image

Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • Report
  • 203 Pages
  • Global
From

About the Genotyping Market

The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods. The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market. Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.